The PI3K/Akt/mTOR pathway is dysfunctional in many tumors, promoting the biological processes of proliferation, invasion and evasion of cell death (Miricescu et al., 2021), but drug resistance in breast cancer (Dong et al., 2021). This evidence concerns the gene PIK3CA and breast carcinoma.